Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 1/5/2026

Contraindications for Iron Supplementation

Absolute Contraindications

  • Iron supplementation is contraindicated in patients with hemochromatosis and other iron overload disorders, as it can exacerbate the condition and increase the risk of tissue damage to the liver, heart, and pancreas 1
  • Iron supplementation is not recommended for patients with normal or elevated ferritin levels, as it can be potentially harmful 2, 3
  • All iron chelation drugs are contraindicated in pregnancy 1
  • Dose adjustment is required in renal failure for iron chelation drugs 1

Relative Contraindications/Precautions

  • Iron supplementation is not recommended for patients with active infection, as iron may promote bacterial growth 4
  • IV iron should be avoided during periods of neutropenia, as infused iron may be used by microorganisms 5
  • Same-day administration of IV iron and anthracyclines should be avoided due to the theoretical risk that iron may potentiate cardiotoxicity 5

Special Considerations

  • Iron parameters can be misleading in the presence of inflammation, requiring careful assessment before supplementation 2, 3
  • Functional iron deficiency in inflammatory conditions may require different approaches to iron supplementation 5
  • Oral iron can cause gastrointestinal side effects, such as nausea, constipation, or diarrhea, which may limit tolerability 6

Monitoring Requirements

  • Ferritin levels should be monitored to prevent iron overload, with target levels during maintenance therapy between 50-100 μg/L 1
  • Liver and renal function should be monitored monthly for patients on iron chelators like deferasirox (DFX) 1
  • Audiological and ophthalmological review should be performed prior to starting iron chelation treatment and annually thereafter 1

Safety Warnings

  • IV iron can cause reactions that may rarely be life-threatening, although this is very infrequent with newer formulations at <1:250,000 administrations 2
  • High molecular weight iron dextran is associated with an increased risk of anaphylactic reactions compared to other iron preparations and should be avoided 7

Oral Iron Supplementation: Contraindications and Management Guidelines

Indications & Absolute Contraindications

Relative Contraindications & Precautions

Clinical Situations Requiring Alternative Approaches

Monitoring & Safety Thresholds

REFERENCES

2

espen micronutrient guideline. [LINK]

Clinical Nutrition, 2022

3

espen micronutrient guideline. [LINK]

Clinical Nutrition, 2022

4

cancer- and chemotherapy-induced anemia. [LINK]

Journal of the National Comprehensive Cancer Network : JNCCN, 2012

5

diagnosis and treatment of cancer-related anemia. [LINK]

American Journal of Hematology, 2014